KB-107

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameKB-107

Drug Alias NameKB-107

ClassificationCell and gene therapy > Gene therapy

Mechanisms of ActionGene transference

TargetsNot applicable

Therapy Area/IndicationsEpidermolysis Bullosa

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesKrystal Biotech Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsEpidermolysis Bullosa

Inactive IndicationsN/A

ATC CodeN/A